Skip to main content

Dr. Timothy D. Mcclure, M.D.

Interventional Radiology (Vascular & Interventional Radiology Physician)

  • Medicare participating

At a glance

Years since graduation
22
In the NPI registry since
2008
Medicare patients seen, 2024
523

Licensed in California since 2006, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2004Medical school: University of Washington School of Medicine
  • 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Vascular & Interventional Radiology Physician primary
    CA license A95976 (first issued 2006; current)
  • Diagnostic Radiology Physician
    CA license A95976 (first issued 2006; current)
  • Urology Physician
    CA license A95976 (first issued 2006; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Interventional Radiology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
523
Services billed
1,267
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 20-29 minutes255213
Established patient office or other outpatient visit, 30-39 minutes188150
Ultrasound scan of pelvic region through rectum123123
Biopsy of prostate gland113113
Insertion of needle into vein for collection of blood sample4946
Review by radiologist of ct guidance for needle placement4645
New patient office or other outpatient visit, 30-44 minutes4242
New patient office or other outpatient visit, 45-59 minutes4141
Ultrasound measurement of bladder capacity after voiding4135
Needle biopsy of kidney4039

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Payments from drug and device companies

In 2025, 6 companies reported 21 payments worth $17,515 in total to this clinician.

By company
Telix Pharmaceuticals$13,837
Pfizer Inc.$2,880
GE Healthcare$500
Galvanize Therapeutics, Inc$140
Angiodynamics, Inc.$122
Argon Medical Devices, Inc.$36.43
By type
Consulting Fee$13,318
Travel and Lodging$3,081
Food and Beverage$1,117

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jan 23, 2025Pfizer Inc.
Jan 23, 2025
Consulting Fee
TALZENNA · ONCOLOGY
$2,880
Aug 7, 2025Telix Pharmaceuticals
Aug 7, 2025
Travel and Lodging
travel to NEW ORLEANS, LA
$2,438
Aug 7, 2025Telix Pharmaceuticals
Aug 7, 2025
Consulting Fee$2,438
Aug 7, 2025Telix Pharmaceuticals
Aug 7, 2025
Consulting Fee$2,250
Aug 7, 2025Telix Pharmaceuticals
Aug 7, 2025
Consulting Fee$2,250
Sep 11, 2025Telix Pharmaceuticals
Sep 11, 2025
Consulting Fee
ILLUCCIX · PROSTATE CANCER DIAGNOSIS
$1,500
Sep 11, 2025Telix Pharmaceuticals
Sep 11, 2025
Consulting Fee
ILLUCCIX · PROSTATE CANCER DIAGNOSIS
$1,500
Jul 16, 2025GE Healthcare
Jul 16, 2025
Consulting Fee
OEC · Imaging - Molecular Imaging Surgical Imaging
$500
Jun 23, 2025Telix Pharmaceuticals
Jun 23, 2025
Travel and Lodging
travel to NEW ORLEANS, LA
$328
Jun 13, 2025Telix Pharmaceuticals
Jun 13, 2025
Travel and Lodging
ILLUCCIX; ILLUCCIX · PROSTATE CANCER DIAGNOSIS · travel to NEW ORLEANS, LA
$316

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in New York →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $276,281 in research payments for these studies, mostly to the institutions running them.

  • RTIRE IIT
    Angiodynamics, Inc.
  • Escape - evaluation of prostate specific membrane antigen positron emission tomography-computed tomography in active surveillance for prostate cancer
    Progenics Pharmaceuticals, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Interventional Radiology clinicians in New York

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 28, 2021), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1992977342. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.